Pascal Pujol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Are We Ready for Systematic Newborn Genome Sequencing?

Routine sampling and analysis of newborn DNA would enable screening for hundreds of childhood genetic diseases, but also raises concerns about privacy and ethics.

United statesNew yorkUnited kingdomFrance generalNorth carolinaRobert guthriePascal pujolDavid geneviNewborn genomes programmeFrench association of clinical geneticistsUniversity of montpellierCurrent international trialsFrench society of predictiveDijon specialist teamFrench associationClinical geneticists

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

Phil febboJean perrinPascal pujolToulouse oncopoleResearch usePrnewswire illumina incFrench society for predictiveClermont ferrand university hospitalJean perrin centerBordeaux university hospital centerChief medical officerGeneral directorProfessor pascal pujolFrench societyPersonalized medicineOncogenetics department

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Karen birminghamPhil febboJean perrinPascal pujolToulouse oncopoleJean perrin centerBordeaux university hospital centerResearch useFrench society for predictiveIllumina incClermont ferrand university hospitalChief medical officerGeneral directorProfessor pascal pujolFrench societyPersonalized medicine

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer - read this article along with other careers information, tips and advice on BioSpace

Karen birminghamPhil febboPascal pujolToulouse oncopoleJean perrin centerBordeaux university hospital centerResearch usePrnewswire illumina incFrench society for predictiveIllumina incClermont ferrand university hospitalChief medical officerGeneral directorProfessor pascal pujolFrench societyPersonalized medicine

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

/PRNewswire/ Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to.

Karen birminghamPhil febboJean perrinPascal pujolResearch useFrench society for predictiveIllumina incJean perrin centerChief medical officerGeneral directorProfessor pascal pujolFrench societyPersonalized medicineOncogenetics departmentMontpellier universityOne genomics